Anagrelide is a drug used for the treatment of essential thrombocytosis (ET;
essential thrombocythemia), or overproduction of blood platelets. It also has been
Aug 5, 2015 ... Learn about Agrylin (Anagrelide) may treat, uses, dosage, side effects, drug
interactions, warnings, patient labeling, reviews, and related ...
Anagrelide is used to decrease the number of platelets (a type of blood cell that is
needed to control bleeding) in the blood of patients who have a bone marrow ...
Type, Small Molecule. Groups, Approved. Description. Anagrelide is a drug used
for the treatment of essential thrombocytosis (ET; essential thrombocythemia).
Agrylin (anagrelide hydrochloride) 0.5 mg Capsules Drug Safety Labeling
Changes July 2015, October 2014, February 2014, July 2013, November 2011,
Medscape - Indication-specific dosing for Agrylin (anagrelide), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Anagrelide (Agrylin) is an oral drug used to treat thrombocythemia (high platelet
count). Learn about side effects, warnings, dosage, and more.
(anagrelide hydrochloride). Dosage Form: 0.5 mg capsules for oral
administration. Active Ingredient: AGRYLIN. ®. Capsules contain 0.5 mg of
anagrelide base ...
Aug 4, 2016 ... Mylan Pharmaceuticals discontinued anagrelide capsules in 2015. Teva could
not ... Anagrelide Hydrochloride oral capsule, Teva. 0.5 mg, 100 ...
www.medicines.org.uk/emc/medicine/15737/SPC/Xagrid 0.5mg hard capsule/
May 5, 2015 ... The effects of treatment with anagrelide must be monitored on a regular basis (
see section 4.4). If the starting dose is > 1 mg/day platelet counts ...